Background: Following the World Health Organization (WHO) recommendations for 4-
weekly antenatal intermittent preventive treatment of malaria in pregnancy using …

Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus
amodiaquine to children 3–59 months is a malaria preventive intervention used for the …

Evolution of gene expression frequently drives antibiotic resistance in bacteria. We had
previously (Patel and Matange, eLife, 2021) shown that in Escherichia coli, mutations at the …

Résumé Malgré tous les efforts d'investissement de ces deux dernières décennies pour la
lutte contre le paludisme, cette maladie demeure la première endémie en Afrique …

By 2030, an estimated two billion international tourist trips are expected annually worldwide,
with Poland as an important contributor. Illness rates among returnees from developing …

Drugs have been used to prevent malaria for centuries, but only recently have they been
used on a large scale to prevent malaria in the resident population of malaria endemic areas …

Malaria infection is one of the most significant public health problems and the leading cause
of global morbidity and mortality. Pregnant women and under-five (U5) children are …

Sulfadoxine-pyrimethamine (SP) is the standard of care for Plasmodium falciparum malaria
chemoprevention among pregnant women, infants, and children. However, SP's antimalarial …

Malaria is caused by parasites called Plasmodium, transmitted through mosquito bites.
Malaria parasites are micro-organisms that belong to the genus Plasmodium. Microscopical …

La Stratégie de riposte face à la résistance aux antipaludiques en Afrique est un document
technique de sensibilisation qui se fonde sur les bases factuelles les plus solides dont on …